ArticleMolecular medicine reports2026
Leptin promotes obesity‑related osteoarthritis progression via CD44/JAK2/STAT3 axis‑mediated chondrocyte apoptosis.
Article in Molecular medicine reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Osteoarthritis (OA), especially obesity‑related OA, is a common joint disease in which leptin serves a notable role; however, the specific mechanism by which leptin promotes obesity‑related OA progression remains unclear. In the present study, human cartilage samples confirmed the association between leptin and obesity‑related OA. The Gene Expression Omnibus dataset GSE85785 was analyzed in R. Differential gene expression was screened using reverse transcription‑quantitative PCR. The protein levels of CD44, apoptosis‑related proteins and Janus kinase 2 (JAK2)/STAT3 pathway‑related proteins were examined using western blotting. Chondrocyte apoptosis was assessed using TUNEL staining and flow cytometry. Cartilage degeneration was evaluated using H&E and Safranin O‑Fast Green staining. Immunofluorescence staining and immunohistochemistry were employed to detect relevant proteins (Leptin, CD44, STAT3). The results from the present study demonstrated that leptin stimulation markedly upregulated CD44 expression, activated the JAK2/STAT3 signaling pathway and induced apoptosis in C28/I2 chondrocytes. Furthermore, the AG490 inhibitor markedly suppressed apoptosis. CD44 knockdown inhibited leptin‑induced activation of the JAK2/STAT3 pathway and apoptosis in C28/I2 chondrocytes, whereas CD44 overexpression activated JAK2/STAT3 signaling and promoted apoptosis. Animal experiments further confirmed that leptin administration induced OA, as shown by histological analysis (H&E and Safranin O‑Fast Green staining) revealing cartilage degeneration and matrix loss and TUNEL staining revealed increased chondrocyte apoptosis in leptin‑treated rats. In summary, the present study identified a novel mechanism by which leptin induced chondrocyte apoptosis and promoted OA through activation of the CD44‑mediated JAK2/STAT3 pathway.
Indexed as
Identifiers
42885301What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.